Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  Celltrion, Inc.    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
10/15/2020 10/16/2020 10/19/2020 10/20/2020 10/21/2020 Date
255000 256500 255500 245500 244000 Last
626565 542735 516612 1215155 607172 Volume
-2.67% +0.59% -0.39% -3.91% -0.61% Change
Financials
Sales 2020 1 721 B 1,51 B 1,51 B
Net income 2020 543 B 0,48 B 0,48 B
Net cash position 2020 439 B 0,39 B 0,39 B
P/E ratio 2020 60,8x
Yield 2020 0,01%
Sales 2021 2 122 B 1,87 B 1,87 B
Net income 2021 701 B 0,62 B 0,62 B
Net cash position 2021 847 B 0,74 B 0,74 B
P/E ratio 2021 47,7x
Yield 2021 0,01%
Capitalization 32 830 B 28 816 M 28 857 M
EV / Sales 2020 19 077x
EV / Sales 2021 15 472x
Nbr of Employees 908
Free-Float 66,7%
More Financials
Company
Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical... 
More about the company
Notations Surperformance© of Celltrion, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about CELLTRION, INC.
10/14CELLTRION : COVID-19 antibody treatment to enter Phase III trial
AQ
10/12S.Korea shares extend rally to eighth day on U.S. stimulus hopes
RE
10/12CELLTRION : South Korea's Celltrion gets approval for Phase 3 trials of COVID-19..
RE
09/28Investors swamp IPO for K-Pop band BTS management label, prices at top of ran..
RE
09/28S.Korea shares jump most in two weeks on falling virus cases, upbeat China da..
RE
09/27Investors swamp IPO for K-Pop band BTS management label, prices at top of ran..
RE
09/25South Korea's Celltrion to merge with affiliates to set up holding company st..
RE
09/25S.Korea stocks post sharpest weekly fall in 6 months
RE
09/24S.Korean shares close at near 2-month low as economic recovery falters
RE
09/21S.Korea stocks dip as global virus concerns offset domestic export boost
RE
09/17South Korea approves Phase 2/3 trials of Celltrion COVID-19 antibody drug
RE
09/14CELLTRION : Phase I trial finds potential COVID-19 antibody treatment safe in he..
AQ
09/08CELLTRION : South Korea's Celltrion to begin commercial production of COVID-19 a..
RE
09/08S.Korea's Celltrion to begin commercial production of COVID-19 antibody drug
RE
08/11S.Korea shares track Wall Street lower, snap seven-day rally on U.S. stimulus..
RE
More news
News in other languages on CELLTRION, INC.
08/10CELLTRION, INC. : Veröffentlichung des Halbjahresergebnisses
08/10CELLTRION, INC. : publication des résultats semestriels
06/11Tokyo démarre en forte baisse, inquiétudes sur les Etats-Unis
2018SEVERIN SCHWAN : Roche cherche à se dégager de la menace des biosimilaires
2018USA : Teva espère lancer son traitement de la migraine dès septembre
More news
Chart CELLTRION, INC.
Duration : Period :
Celltrion, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLTRION, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 309 888,89 KRW
Last Close Price 245 500,00 KRW
Spread / Highest target 83,3%
Spread / Average Target 26,2%
Spread / Lowest Target -50,3%
EPS Revisions
Managers
NameTitle
Wu-Sung Ki Chief Executive Officer & Director
Jung-Jin Seo Chairman
Ho-Seop Lee Finance Director
Dong-Il Kim Independent Director
Joseph Lee Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CELLTRION, INC.35.64%29 974
LONZA GROUP AG64.78%47 531
SEAGEN INC.73.48%34 490
IQVIA HOLDINGS INC.6.17%31 378
MODERNA, INC.262.78%28 000
IMMUNOMEDICS, INC.314.04%20 266